Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012308231> ?p ?o ?g. }
- W2012308231 endingPage "35" @default.
- W2012308231 startingPage "29" @default.
- W2012308231 abstract "The purpose of this study was to evaluate the role of interferon as initial and maintenance therapy in patients with newly diagnosed follicular lymphoma. Between 1984 and 1994, 204 patients with newly diagnosed Stage III or Stage IV follicular lymphoma were randomized to receive either, Chlorambucil (CB): 10 mg daily for 6 weeks, followed by a 2-week interval, with 3 subsequent 2-week treatment periods at the same dose, separated by 2-week intervals, or, CB given concurrently with interferon (IFN). IFN was given at a dose of 3 x 10(6)units thrice weekly, subcutaneously, throughout the 18-week treatment period. Responding patients were subsequently randomized to receive maintenance IFN at the dose and schedule described above, or to expectant management. The overall response rate was 161/204 (78%), complete remission being achieved in 24% of patients. Neither the addition of IFN to the initial treatment, nor the use of maintenance IFN influenced response rate, remission duration or survival. This study was undertaken to determine whether IFN, given in combination with, and then subsequent to, CB would alter the clinical course of patients with follicular lymphoma. Disappointingly, this objective was not achieved, no advantage having been demonstrated for the addition of IFN." @default.
- W2012308231 created "2016-06-24" @default.
- W2012308231 creator A5011398209 @default.
- W2012308231 creator A5016566297 @default.
- W2012308231 creator A5020582543 @default.
- W2012308231 creator A5023762401 @default.
- W2012308231 creator A5025307148 @default.
- W2012308231 creator A5048555023 @default.
- W2012308231 creator A5083306545 @default.
- W2012308231 creator A5036829932 @default.
- W2012308231 date "2001-07-01" @default.
- W2012308231 modified "2023-10-14" @default.
- W2012308231 title "A randomized controlled trial to evaluate the role of interferon as initial and maintenance therapy in patients with follicular lymphoma" @default.
- W2012308231 cites W1504115866 @default.
- W2012308231 cites W1521231175 @default.
- W2012308231 cites W1595896331 @default.
- W2012308231 cites W1849027585 @default.
- W2012308231 cites W1892026381 @default.
- W2012308231 cites W1921096083 @default.
- W2012308231 cites W1924771936 @default.
- W2012308231 cites W1933173754 @default.
- W2012308231 cites W1988493767 @default.
- W2012308231 cites W1992964537 @default.
- W2012308231 cites W1994543822 @default.
- W2012308231 cites W1996549520 @default.
- W2012308231 cites W2006075926 @default.
- W2012308231 cites W2007847579 @default.
- W2012308231 cites W2012673663 @default.
- W2012308231 cites W2020387413 @default.
- W2012308231 cites W2034902182 @default.
- W2012308231 cites W2035469650 @default.
- W2012308231 cites W2036782092 @default.
- W2012308231 cites W2037650318 @default.
- W2012308231 cites W2042650523 @default.
- W2012308231 cites W2048311499 @default.
- W2012308231 cites W2055758159 @default.
- W2012308231 cites W2065271139 @default.
- W2012308231 cites W2080172562 @default.
- W2012308231 cites W2088455335 @default.
- W2012308231 cites W2093312029 @default.
- W2012308231 cites W2093767787 @default.
- W2012308231 cites W2122973550 @default.
- W2012308231 cites W2127593282 @default.
- W2012308231 cites W2128112098 @default.
- W2012308231 cites W2128997140 @default.
- W2012308231 cites W2137114600 @default.
- W2012308231 cites W2144360148 @default.
- W2012308231 cites W2155001516 @default.
- W2012308231 cites W2170313932 @default.
- W2012308231 cites W2171796002 @default.
- W2012308231 cites W2179208207 @default.
- W2012308231 cites W2180626928 @default.
- W2012308231 cites W2240465506 @default.
- W2012308231 cites W2249107533 @default.
- W2012308231 cites W2253479946 @default.
- W2012308231 cites W2261415372 @default.
- W2012308231 cites W2269595883 @default.
- W2012308231 cites W2328311363 @default.
- W2012308231 cites W2339387502 @default.
- W2012308231 cites W2339932366 @default.
- W2012308231 cites W2396514826 @default.
- W2012308231 cites W2415634187 @default.
- W2012308231 cites W2415938066 @default.
- W2012308231 cites W2468075231 @default.
- W2012308231 cites W2588779176 @default.
- W2012308231 cites W4230978190 @default.
- W2012308231 cites W4293241248 @default.
- W2012308231 doi "https://doi.org/10.1054/bjoc.2001.1822" @default.
- W2012308231 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2363909" @default.
- W2012308231 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11437398" @default.
- W2012308231 hasPublicationYear "2001" @default.
- W2012308231 type Work @default.
- W2012308231 sameAs 2012308231 @default.
- W2012308231 citedByCount "48" @default.
- W2012308231 countsByYear W20123082312012 @default.
- W2012308231 countsByYear W20123082312013 @default.
- W2012308231 countsByYear W20123082312014 @default.
- W2012308231 countsByYear W20123082312019 @default.
- W2012308231 countsByYear W20123082312020 @default.
- W2012308231 crossrefType "journal-article" @default.
- W2012308231 hasAuthorship W2012308231A5011398209 @default.
- W2012308231 hasAuthorship W2012308231A5016566297 @default.
- W2012308231 hasAuthorship W2012308231A5020582543 @default.
- W2012308231 hasAuthorship W2012308231A5023762401 @default.
- W2012308231 hasAuthorship W2012308231A5025307148 @default.
- W2012308231 hasAuthorship W2012308231A5036829932 @default.
- W2012308231 hasAuthorship W2012308231A5048555023 @default.
- W2012308231 hasAuthorship W2012308231A5083306545 @default.
- W2012308231 hasBestOaLocation W20123082311 @default.
- W2012308231 hasConcept C126322002 @default.
- W2012308231 hasConcept C141071460 @default.
- W2012308231 hasConcept C168563851 @default.
- W2012308231 hasConcept C187785154 @default.
- W2012308231 hasConcept C203014093 @default.
- W2012308231 hasConcept C2776178377 @default.
- W2012308231 hasConcept C2776694085 @default.
- W2012308231 hasConcept C2776755627 @default.
- W2012308231 hasConcept C2777058707 @default.